Taylor Ben R (CIK 1712276) reported 24 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Sell RXRX (5,396 shares), Sell RXRX (25,018 shares), Sell RXRX (48,028 shares), Sell RXRX (7,075 shares), Sell RXRX (7,956 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 5,396 | $16,997 |
| 2026-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 25,018 | $76,055 |
| 2026-04-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 48,028 | $149,367 |
| 2026-03-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,075 | $24,196 |
| 2026-03-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,956 | $26,971 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 11,908 | $41,559 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 13,426 | $41,352 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Buy | 446,279 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Buy | 24,254 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 11,400 | $45,372 |
| 2025-12-30 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 21,383 | $89,381 |
| 2025-12-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,057 | $30,557 |
| 2025-11-26 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 2,271 | $9,152 |
| 2025-11-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 11,908 | $49,299 |
| 2025-09-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,057 | $34,085 |
| 2025-08-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 11,908 | $67,161 |
| 2025-06-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,057 | $34,720 |
| 2025-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 11,908 | $50,609 |
| 2025-04-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 26,571 | $135,512 |
| 2025-03-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 7,057 | $48,270 |
| 2025-02-20 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 10,879 | $115,753 |
| 2025-02-05 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Buy | 35,018 | $0 |
| 2025-02-05 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Buy | 13,922 | $0 |
| 2025-02-05 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | Sell | 6,544 | $47,444 |
Source: SEC Form 4 filings · as of 2026-06-17